Lotta Ferm appointed as interim CFO at Medivir
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) as previously announced, Erik Björk will leave the role as Medivir’s CFO. Lotta Ferm will assume the role as interim CFO as of March 1st. Recruitment of a permanent CFO is ongoing. For further information, please contact:Uli Hacksell, CEO, Medivir AB, mobile: +46 (0)73 125 0615. About MedivirMedivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The company is investing in indication areas where available therapies are limited or missing and there are great opportunities to offer